Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.54 USD | -4.15% | -5.40% | +89.55% |
Mar. 20 | Transcript : Trevi Therapeutics, Inc., Q4 2023 Earnings Call, Mar 20, 2024 | |
Mar. 20 | Trevi Therapeutics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Financials (USD)
Sales 2024 * | - | Sales 2025 * | - | Capitalization | 175M |
---|---|---|---|---|---|
Net income 2024 * | -41M | Net income 2025 * | -53M | EV / Sales 2024 * | - |
Net cash position 2024 * | 116M | Net cash position 2025 * | 199M | EV / Sales 2025 * | - |
P/E ratio 2024 * |
-6.47
x | P/E ratio 2025 * |
-5.74
x | Employees | 25 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 98.72% |
Latest transcript on Trevi Therapeutics, Inc.
1 day | -4.15% | ||
1 week | -5.40% | ||
Current month | -26.38% | ||
1 month | -24.18% | ||
3 months | +90.98% | ||
6 months | +47.67% | ||
Current year | +89.55% |
Managers | Title | Age | Since |
---|---|---|---|
Jennifer Good
FOU | Founder | 59 | 11-02-28 |
Thomas Sciascia
FOU | Founder | 70 | 10-12-31 |
Lisa Delfini
DFI | Director of Finance/CFO | 54 | 21-08-08 |
Members of the board | Title | Age | Since |
---|---|---|---|
Anne VanLent
BRD | Director/Board Member | 76 | 18-10-09 |
James Cassella
BRD | Director/Board Member | 69 | 20-02-12 |
Jennifer Good
FOU | Founder | 59 | 11-02-28 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.00% | 34 M€ | +2.22% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-04-25 | 2.54 | -4.15% | 177,374 |
24-04-24 | 2.65 | -7.02% | 124,912 |
24-04-23 | 2.85 | -3.06% | 172,800 |
24-04-22 | 2.94 | +3.70% | 195,512 |
24-04-19 | 2.835 | +5.59% | 144,472 |
Delayed Quote Nasdaq, April 25, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+89.55% | 183M | |
-2.26% | 104B | |
+1.41% | 97.42B | |
+0.79% | 22.2B | |
-17.84% | 21.23B | |
-11.11% | 18.33B | |
-42.83% | 16.35B | |
-17.63% | 15.06B | |
+4.55% | 13.98B | |
+32.11% | 11.66B |
- Stock Market
- Equities
- TRVI Stock